Biogen Idec Financial Statements
Biogen Idec Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Biogen Idec Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,171.6 | 2,683.1 | 2,422.5 |
| Gross Profit ($ mil.) | 2,836.4 | 2,408.7 | 2,048.9 |
| Operating Income ($ mil.) | 779.8 | 440.0 | 236.0 |
| Total Net Income ($ mil.) | 638.2 | 217.5 | 160.7 |
| Diluted EPS (Net Income) | 1.99 | 0.63 | 0.47 |
Biogen Idec Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 993.4 | 942.2 | 893.3 |
| Gross Profit ($ mil.) | 901.0 | 841.3 | 805.7 |
| Operating Income ($ mil.) | 296.8 | 246.0 | 262.4 |
| Total Net Income ($ mil.) | 206.6 | 163.1 | 201.1 |
| Diluted EPS (Net Income) | 0.70 | 0.54 | 0.65 |
Biogen Idec Stock Quote & Chart
10/10/08 15:00:17 EST •
NASDAQ •
42.78
•
 -1.9800
•
-4.4236 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Biogen Idec Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.74 | 3.14 | 1.38 |
| Price/Earnings Ratio | 19.83 | 13.59 | 14.44 |
| Price/Book Ratio | 2.45 | 2.53 | 1.34 |
| Price/Cash Flow Ratio | 11.28 | 11.92 | 8.71 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Biogen Idec Financial Ratios
Biogen Idec Competitive Intelligence
| Bayer HealthCare Pharmaceuticals | Bristol-Myers Squibb | Merck Serono | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,258.9 | 19,348.0 | 2,586.4 |
| Employees | 2,000 | 42,000 | 4,826 |
| Market Cap ($ mil.) | -- | 42,539.7 | -- |
Competitive Landscape
